Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Quest Laboratories's Enterprise Value is ₹1,417 Mil.
Quest Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹200 Mil. Therefore, Quest Laboratories's EV-to-EBIT ratio for today is 7.10.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Quest Laboratories's Enterprise Value is ₹1,417 Mil.
Quest Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹208 Mil. Therefore, Quest Laboratories's EV-to-EBITDA ratio for today is 6.82.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Quest Laboratories's Enterprise Value is ₹1,417 Mil.
Quest Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,118 Mil. Therefore, Quest Laboratories's EV-to-Revenue ratio for today is 1.27.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Quest Laboratories (NSE:QUESTLAB) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Quest Laboratories's current Enterprise Value is ₹1,417 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Quest Laboratories's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was ₹200 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Quest Laboratories's current Enterprise Value is ₹1,417 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Quest Laboratories's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹208 Mil.
Quest Laboratories's current Enterprise Value is ₹1,417 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Quest Laboratories's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was ₹1,118 Mil.
Quest Laboratories's current Enterprise Value is ₹1,417 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Quest Laboratories's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-107 Mil.
Quest Laboratories's current Enterprise Value is ₹1,417 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Quest Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-160 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest Laboratories Enterprise Value Related Terms
Quest Laboratories Enterprise Value Historical Data
* Premium members only.
The historical data trend for Quest Laboratories's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:QUESTLAB vs LLY, JNJ, ABBV: Enterprise Value Comparison
For the Drug Manufacturers - General subindustry, Quest Laboratories's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Laboratories Enterprise Value vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Quest Laboratories's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Quest Laboratories's Enterprise Value for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Quest Laboratories (NSE:QUESTLAB) has a Enterprise Value of ₹1,417 Mil as of Aug. 10, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Quest Laboratories and its competitors.
Is Quest Laboratories' Enterprise Value too high?
Quest Laboratories' current Enterprise Value is ₹1,417 Mil. Overall, Quest Laboratories has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' Enterprise Value compare to LLY and JNJ?
Quest Laboratories' Enterprise Value of ₹1,417 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Drug Manufacturers company?
A good Enterprise Value depends on the Drug Manufacturers industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Quest Laboratories and its competitors. Quest Laboratories's current Enterprise Value is ₹1,417 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current Enterprise Value of ₹1,417 Mil. The current Enterprise Value is ₹1,417 Mil. Quest Laboratories' overall GF Score™ is 46/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current Enterprise Value is ₹1,417 Mil as of Aug. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
46GF Score
Get the complete analysis for NSE:QUESTLAB
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUESTLAB has been successfully added to your 
